FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson's Disease
Links shared publicly online about this topic.
- 1,360total visits
FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson's Disease
View full resource at drugs.com
Tags: Parkinson's Disease, Parkinson's Disease Medication, Neuropathic Pain Medication, Disease and Condition, FDA, Sifrol, Mirapex
Most Recently Shared on February 23, 2010 at 10:21 pm By:
FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson's Disease - http://bit.ly/98Mvry
FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.” View full resource at news-medical.net
Most Recently Shared on March 26, 2010 at 11:38 am By:
Parkinson's Disease: FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD: Boehringer Ingelheim... http://bit.ly/9ct9qR
Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
drugs.com — “Mirapex ER (pramipexole dihydrochloride) is used to treat Early and Advanced Parkinson's Disease. Includes Mirapex ER side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 24, 2010 at 10:27 pm By:
Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease - http://bit.ly/buiaNc
Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablet” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2010 at 12:37 pm By:
Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease Boehringer Ingelheim Pharma.. http://bit.ly/ahPstx
Medical News: FDA Okays Once-Daily Parkinson's Drug - in Neurology, Parkinson's Disease from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved an extended release version of pramipexole (Mirapex ER) for patients with early Parkinson's disease.” View full resource at medpagetoday.com
Most Recently Shared on February 24, 2010 at 4:07 pm By:
FDA Okays Once-Daily Parkinson's Drug WASHINGTON (MedPage Today) -- The FDA has approved an extended release version .. http://bit.ly/aP4x1P
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new on” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 2:11 pm By:
MNT Parkinson's News Health News
FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease http://mnt.to/3xY5 #parkinsons
Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., ” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 10:12 am By:
Parkinson's Disease: Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of ear... http://bit.ly/c33J2g
Mirapex ER approved for early Parkinson's disease - ONA
oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer-Ingelheim Pharmaceuticals) as a treatment for the signs and symptoms of early idiopathic Parkinson--™s disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 22, 2010 at 5:44 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Mirapex ER approved for early Parkinson's disease http://goo.gl/fb/pcsE
Advertisement
